These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15335311)

  • 1. Gene therapy of epidermolysis bullosa.
    Bauer JW; Laimer M
    Expert Opin Biol Ther; 2004 Sep; 4(9):1435-43. PubMed ID: 15335311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.
    Pulkkinen L; Uitto J
    Exp Dermatol; 1998; 7(2-3):46-64. PubMed ID: 9583744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa.
    Christiano AM; Uitto J
    Exp Dermatol; 1996 Feb; 5(1):1-11. PubMed ID: 8624605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
    Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
    J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent failures in gene repair.
    van der Steege G; Schuilenga-Hut PH; Buys CH; Scheffer H; Pas HH; Jonkman MF
    Nat Biotechnol; 2001 Apr; 19(4):305-6. PubMed ID: 11283576
    [No Abstract]   [Full Text] [Related]  

  • 6. BP180 gene delivery in junctional epidermolysis bullosa.
    Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
    Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.
    Bauer JW; Lanschuetzer C
    Clin Exp Dermatol; 2003 Jan; 28(1):53-60. PubMed ID: 12558632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa.
    Bruckner-Tuderman L; Rüegger S; Odermatt B; Mitsuhashi Y; Schnyder UW
    Dermatologica; 1988; 176(2):57-64. PubMed ID: 3286309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis and molecular genetics of epidermolysis bullosa.
    Pulkkinen L; Uitto J
    Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Epidermolysis Bullosa.
    Marinkovich MP; Tang JY
    J Invest Dermatol; 2019 Jun; 139(6):1221-1226. PubMed ID: 31068252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain.
    Tasanen K; Floeth M; Schumann H; Bruckner-Tuderman L
    J Invest Dermatol; 2000 Aug; 115(2):207-12. PubMed ID: 10951237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa.
    Mellerio JE; Denyer JE; Atherton DJ; Eady RA; McGrath JA
    Br J Dermatol; 1998 Apr; 138(4):661-6. PubMed ID: 9640376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistopathologic diagnosis of epidermolysis bullosa.
    Bergman R
    Am J Dermatopathol; 1999 Apr; 21(2):185-92. PubMed ID: 10218683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy.
    Harman KE; Bhogal BS; Eady RA; McGrath JA; Black MM
    Br J Dermatol; 1999 Sep; 141(3):475-80. PubMed ID: 10583051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for inherited bullous diseases.
    Korge BP; Krieg T
    J Mol Med (Berl); 1996 Feb; 74(2):59-70. PubMed ID: 8820401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
    Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
    Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural findings in epidermolysis bullosa.
    Smith LT
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.
    Fontao L; Tasanen K; Huber M; Hohl D; Koster J; Bruckner-Tuderman L; Sonnenberg A; Borradori L
    J Invest Dermatol; 2004 Jan; 122(1):65-72. PubMed ID: 14962091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain.
    Pasmooij AM; van Zalen S; Nijenhuis AM; Kloosterhuis AJ; Zuiderveen J; Jonkman MF; Pas HH
    Exp Dermatol; 2004 Feb; 13(2):125-8. PubMed ID: 15009107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.